Beacon Pharmaceuticals (DHA:BEACONPHAR) Total Inventories : BDT2,815 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Beacon Pharmaceuticals Total Inventories?

Beacon Pharmaceuticals's total inventories for the quarter that ended in Dec. 2023 was BDT2,815 Mil. Beacon Pharmaceuticals's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was BDT2,397 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Beacon Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was BDT-30.32.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Beacon Pharmaceuticals's Days Inventory for the three months ended in Dec. 2023 was 166.30.

Inventory Turnover measures how fast the company turns over its inventory within a year. Beacon Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.55.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Beacon Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.86.

Beacon Pharmaceuticals Total Inventories Historical Data

The historical data trend for Beacon Pharmaceuticals's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beacon Pharmaceuticals Total Inventories Chart

Beacon Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Inventories

Get a 7-Day Free Trial

1,004.26

1,032.59

1,278.65

1,971.94

1,991.66

Beacon Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial															2,009.46	1,742.32	1,991.66	1,980.15	2,814.62

Beacon Pharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Beacon Pharmaceuticals (DHA:BEACONPHAR) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Beacon Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1072.809	+	0.75 * 2607	+	0.5 * 2814.622	-	11440.057
-	0	-	0)	/	231.000
=	-30.32

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Beacon Pharmaceuticals's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	2397.388	/	1315.477	*	365 / 4
	=	166.30

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Beacon Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	1315.477	/	2397.388
	=	0.55

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Beacon Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2397.388	/	2781.186
	=	0.86

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Beacon Pharmaceuticals Total Inventories Related Terms

Thank you for viewing the detailed overview of Beacon Pharmaceuticals's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Beacon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » Total Inventories

Traded in Other Exchanges

N/A

Address

9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223

Website

https://www.beaconpharma.com.bd

Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.

Beacon Pharmaceuticals Headlines

No Headlines